<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-01T06:03:31Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/24756" metadataPrefix="mods">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/24756</identifier><datestamp>2026-02-03T12:13:36Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><mods:mods xmlns:doc="http://www.lyncode.com/xoai" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
   <mods:name>
      <mods:namePart>Cantero-García, Noelia</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Flores-Burgess, Antonio</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Ladrón de Guevara-Miranda, David</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Serrano, Antonia</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>García-Durán, Laura</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Puigcerver-Martínez, Araceli</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Fuxe, Kjell</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Narváez-Bueno, José Ángel</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Santín-Núñez, Luis Javier</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Díaz-Cabiale,  Zaida</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Millón-Peñuela, Carmelo</mods:namePart>
   </mods:name>
   <mods:extension>
      <mods:dateAvailable encoding="iso8601">2022-07-21T11:46:37Z</mods:dateAvailable>
   </mods:extension>
   <mods:extension>
      <mods:dateAccessioned encoding="iso8601">2022-07-21T11:46:37Z</mods:dateAccessioned>
   </mods:extension>
   <mods:originInfo>
      <mods:dateIssued encoding="iso8601">2022-07-12</mods:dateIssued>
   </mods:originInfo>
   <mods:identifier type="uri">https://hdl.handle.net/10630/24756</mods:identifier>
   <mods:abstract>Recently, we described that Galanin(1-15)[GAL(1-15)] enhanced Escitalopram(ESC) effectiveness in depression symptoms. Moreover GAL(1-15) induces a substantial reduction in alcohol consumption. To investigate the effect of GAL(1-15) on ESC-activity in depression-alcoholism comorbidity, we used the ethanol self-administration test and the forced swimming test(FST) in rats, after a chronic alcohol consumption. Also to study if GAL(1-15)+ESC modulate the reward system induced by different reinforcers we have analyzed this combination in the saccharine self-administration test.&#xd;
Groups of rats received three times intraperitoneal injections of ESC (2.5mg/Kg or 7.5mg/Kg) 23, 5 and 1h before the test and one icv injection of GAL(1-15) (0.3nmol or 1 nmol) 15 minutes before the test. One-way ANOVA followed by Fisher´s least significant difference test was used.&#xd;
In the saccharin self-administration test, the coadministration GAL(1-15)(1nmol) and ESC(2.5mg/Kg) induced a strong reduction in the number of reinforcements of saccharine (p&lt;0.05) and in number of active lever presses (p&lt;0.05).&#xd;
In the ethanol Self-Administration test, GAL(1-15)(0.3nmol) enhanced the reduction of alcohol intake mediated by ESC(2.5mg/Kg). GAL(1-15) decreased the number of alcohol reinforcements (p&lt;0.01) and the number of active levers pressed (p&lt;0.01) by around 50% induced by ESC.  &#xd;
In FST, in rats under a chronic alcohol consumption, GAL(1-15) reversed adverse ESC-mediated effects. The coadministration of GAL(1-15)(1nmol) and ESC(7.5mg/Kg) showed a significant decrease in immobility (p&lt;0.05) and an increase in swimming(p&lt;0.05) compared with ESC group. &#xd;
The results open up the possibility to use GAL(1-15) in combination with Escitalopram as a novel strategy in AUD comorbidity with depression.</mods:abstract>
   <mods:language>
      <mods:languageTerm>eng</mods:languageTerm>
   </mods:language>
   <mods:accessCondition type="useAndReproduction">open access</mods:accessCondition>
   <mods:subject>
      <mods:topic>Alcoholismo - Tratamiento</mods:topic>
   </mods:subject>
   <mods:subject>
      <mods:topic>Depresión mental</mods:topic>
   </mods:subject>
   <mods:subject>
      <mods:topic>Alcohol</mods:topic>
   </mods:subject>
   <mods:titleInfo>
      <mods:title>Galanin (1-15) and escitalopram combination in rats reduces alcohol consumption in the ethanol self-administration test and improves escitalopram effects in the forced swimming test.</mods:title>
   </mods:titleInfo>
   <mods:genre>conference output</mods:genre>
</mods:mods>
</metadata></record></GetRecord></OAI-PMH>